ストックスクリーナーアプリを入手
2.29
0.44%
0.01
アフターアワーズ：
2.33
0.04
+1.75%
Invivyd Inc (IVVD) 最新ニュース
How Recent Clinical Progress Is Rewriting the Story for Invivyd - Yahoo Finance
Is Invivyd Inc. stock undervalued vs historical averagesJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
What sentiment indicators say about Invivyd Inc. stock2025 Sector Review & Smart Money Movement Tracker - Улправда
Is Invivyd Inc. stock a good choice for value investors2025 Historical Comparison & Precise Entry and Exit Recommendations - Улправда
Invivyd, Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade - Yahoo! Finance Canada
Invivyd, Inc. (IVVD): Advancing RSV antibody VBY329 amid analyst downgrade - MSN
Exploring Three High Growth Tech Stocks In The US Market - simplywall.st
Invivyd Nominates RSV Antibody, Spurs Market Interest - StocksToTrade
Invivyd (NASDAQ:IVVD) Stock Price Up 6.1%Still a Buy? - MarketBeat
Invivyd, RF Industries, and DLocal Lead Impressive Stock Returns in Recent Months - Markets Mojo
Maverick Capital Ltd. Has $7.31 Million Position in Invivyd, Inc. $IVVD - MarketBeat
Invivyd (NASDAQ:IVVD) Trading Up 7%Still a Buy? - MarketBeat
Is Invivyd (IVVD) Using RSV Prophylaxis To Redefine Its Post‑COVID Strategy? - simplywall.st
Invivyd (IVVD) Is Down 8.6% After Advancing VBY329 For Pediatric RSV PreventionWhat's Changed - Yahoo Finance
What Analysts Think Is Changing The Story For Invivyd Now - Yahoo Finance
Will Invivyd Inc. stock deliver consistent dividendsWeekly Trend Recap & Daily Oversold Bounce Ideas - Newser
Invivyd (NASDAQ:IVVD) Shares Down 3.8%Here's Why - MarketBeat
Invivyd (NASDAQ:IVVD) Shares Gap UpWhat's Next? - MarketBeat
What catalysts could drive Invivyd Inc. stock higherQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
How Invivyd Inc. stock compares to industry benchmarksJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - Newser
A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development - Yahoo Finance
Optimistic Investors Push Invivyd, Inc. (NASDAQ:IVVD) Shares Up 27% But Growth Is Lacking - simplywall.st
Is Invivyd Inc. stock supported by strong fundamentalsTrade Analysis Summary & Weekly Sector Rotation Insights - moha.gov.vn
Could Invivyd's (IVVD) Pipeline Expansion Reveal a Shift in Its Long-Term Competitive Strategy? - simplywall.st
Invivyd Appoints New Director Amid Nasdaq Compliance - MSN
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights - ADVFN
Invivyd Raises $117.2 Million in Public Offering - MSN
Invivyd, Inc. (NASDAQ:IVVD) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
D. Boral Capital Downgrades Invivyd (IVVD) - MSN
Invivyd (NASDAQ:IVVD) Earns Hold Rating from D. Boral Capital - MarketBeat
This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Invivyd (IVVD) Downgraded to Hold by D. Boral Capital | IVVD Sto - GuruFocus
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference - The Globe and Mail
Kevin McLaughlin Buys Handful Of Shares In Invivyd - simplywall.st
Invivyd (Nasdaq: IVVD) to Join 8th Annual Evercore Healthcare Conference Fireside Chat - Stock Titan
Invivyd nominates promising RSV antibody candidate for infants By Investing.com - Investing.com Australia
Invivyd Unveils Promising RSV Antibody Candidate - TipRanks
New Haven-based biotech firm nets $117M from public offering - Hartford Business Journal
Invivyd Selects Antibody Candidate for Respiratory Syncytial Virus Prevention - MarketScreener
Invivyd nominates promising RSV antibody candidate for infants - Investing.com
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness - The Manila Times
Invivyd, Inc. Advances VBY329 as Promising Monoclonal Antibody Candidate for RSV Prevention in Infants and Children - Quiver Quantitative
[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan
Invivyd (Nasdaq: IVVD) picks RSV antibody VBY329, 1.5-fold potency, IND in 2026 - Stock Titan
Four companies raise nearly $950M in follow-ons: Public Equity Report - BioCentury
What is the fair value of Invivyd Inc. stock nowIPO Watch & AI Driven Stock Reports - newser.com
Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes - MSN
Invivyd Director Kevin F. McLaughlin Acquires 50,000 Shares - TradingView
Dir McLaughlin Buys 50,000 ($125K) Of Invivyd Inc [IVVD] - TradingView
[Form 4] Invivyd, Inc. Insider Trading Activity - Stock Titan
Candlestick signals on Invivyd Inc. stock todayTrade Exit Summary & Consistent Return Investment Signals - newser.com
Can Invivyd Inc. stock deliver surprise earnings beatQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Invivyd announces proposed public offering of common stock - MSN
0.31%
0.33%
大文字化:
|
ボリューム (24 時間):